We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $13.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
+12.16%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.28%
AUM
$11.4B
AUM Growth
+$1.28B
Cap. Flow
+$190M
Cap. Flow %
1.67%
Top 10 Hldgs %
17.01%
Holding
369
New
14
Increased
138
Reduced
152
Closed
7

Top Sells

Rank Stock Value
1
MEDP icon
Medpace
MEDP
+$30.3M
2
AAPL icon
Apple
AAPL
+$23.4M
3
MCO icon
Moody's
MCO
+$22.1M
4
MANH icon
Manhattan Associates
MANH
+$20.9M
5
CPK icon
Chesapeake Utilities
CPK
+$18.7M

Sector Composition

Rank Sector Weight
1 Technology 17.69%
2 Healthcare 17.31%
3 Financials 16.14%
4 Industrials 14.89%
5 Consumer Discretionary 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LSTR icon
101
Landstar System
LSTR
$5.75B
$40.7M 0.36%
249,850
-1,367
-0.5% -$219K
CLB icon
102
Core Laboratories
CLB
$477M
$39.9M 0.35%
1,969,184
-41,958
-2% -$813K
QLYS icon
103
Qualys
QLYS
$4.99B
$39.6M 0.35%
352,687
-1,749
-0.5% -$218K
ES icon
104
Eversource Energy
ES
$27.8B
$39M 0.34%
464,828
-58,750
-11% -$4.66M
SCI icon
105
Service Corp International
SCI
$11.8B
$38.9M 0.34%
562,077
+11,453
+2% +$763K
VMI icon
106
Valmont Industries
VMI
$9.2B
$38.7M 0.34%
116,992
-1,077
-0.9% -$342K
EL icon
107
Estee Lauder
EL
$30.7B
$38.3M 0.34%
154,501
+5,730
+4% +$1.28M
AOS icon
108
A.O. Smith
AOS
$8.24B
$37.9M 0.33%
662,673
+36,509
+6% +$2.04M
CORT icon
109
Corcept Therapeutics
CORT
$12.7B
$37.5M 0.33%
1,846,281
+487,962
+36% +$12.2M
PG icon
110
Procter & Gamble
PG
$335B
$36.9M 0.32%
243,287
+1,907
+0.8% +$267K
PKG icon
111
Packaging Corp of America
PKG
$22.2B
$36.9M 0.32%
288,137
+19,874
+7% +$2.49M
ICUI icon
112
ICU Medical
ICUI
$4.21B
$36.7M 0.32%
233,093
-6,842
-3% -$1.04M
TFX icon
113
Teleflex
TFX
$5.86B
$36.1M 0.32%
144,569
-343
-0.2% -$75.7K
CMI icon
114
Cummins
CMI
$87.3B
$35.9M 0.32%
148,140
+1,765
+1% +$420K
CRVL icon
115
CorVel
CRVL
$3.03B
$35.6M 0.31%
734,613
-3,507
-0.5% -$175K
BMI icon
116
Badger Meter
BMI
$3.78B
$35.4M 0.31%
325,111
-1,533
-0.5% -$166K
RVTY icon
117
Revvity
RVTY
$12.7B
$35.4M 0.31%
252,137
+4,306
+2% +$579K
FELE icon
118
Franklin Electric
FELE
$4.57B
$35.1M 0.31%
440,738
-2,183
-0.5% -$180K
UNF icon
119
Unifirst Corp
UNF
$5.31B
$35M 0.31%
181,425
-761
-0.4% -$139K
AXP icon
120
American Express
AXP
$228B
$35M 0.31%
236,659
+18,280
+8% +$2.71M
COLD icon
121
Americold
COLD
$4.13B
$34.5M 0.3%
1,220,119
-1,346
-0.1% -$36.2K
LAMR icon
122
Lamar Advertising Co
LAMR
$16.3B
$34.5M 0.3%
365,695
+22,301
+6% +$2.06M
WTS icon
123
Watts Water Technologies
WTS
$11.5B
$34.3M 0.3%
234,562
-1,153
-0.5% -$166K
MTX icon
124
Minerals Technologies
MTX
$2.25B
$34.2M 0.3%
562,762
-4,832
-0.9% -$274K
BR icon
125
Broadridge
BR
$17.9B
$34.1M 0.3%
254,457
+790
+0.3% +$112K

Similar funds

Boston Trust Walden's Q4 2022 Portfolio in Review

As of Q4 2022, Boston Trust Walden held 369 positions worth $11.4B, up 13% from $10.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Boston Trust Walden's Q4 2022 filing shows 14 new, 138 increased, 152 reduced and 7 closed positions. Its largest new stake was BJs Wholesale Club: 726,376 shares worth $48.1M. The largest sale was Medpace, an estimated $30.3M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.

  • Boston Trust Walden's largest Q4 2022 buy was BJs Wholesale Club: 726,376 shares worth $48.1M.
  • Boston Trust Walden added most to Littelfuse in Q4 2022, an estimated $25.5M increase.
  • Boston Trust Walden's biggest Q4 2022 reduction was Medpace, cutting an estimated $30.3M.
  • Boston Trust Walden fully exited Chesapeake Utilities in Q4 2022, selling an estimated $18.7M.
  • Boston Trust Walden's ten largest holdings make up 17% of its $11.4B portfolio in Q4 2022.
  • Boston Trust Walden opened 14 new positions and closed 7 in Q4 2022.
  • Boston Trust Walden's portfolio value rose 13% quarter-over-quarter to $11.4B.

Based on Boston Trust Walden's 13F filing for Q4 2022, filed 20 Jan 2023.